CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$11.47
+7.10%
Mkt Cap $780.03M
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (8 analysts)
$20.00
Range $17.00 – $25.00
Implied Upside
+74.4%
Consensus $20.00 vs current $11.47
NASDAQ·Healthcare·Biotechnology
$11.47
+7.10%
Mkt Cap $780.03M
Buy
11
Hold
0
Sell
0
Price Target (8 analysts)
$20.00
Range $17.00 – $25.00
+74.4%
Consensus $20.00 vs current $11.47